Cargando…
A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the second cause of cancer-related death. Search for genes/proteins whose expression can discriminate between normal and neoplastic liver is fundamental for diagnostic, prognostic and therapeutic purposes. Currently, the mo...
Autores principales: | Angioni, Maria Maddalena, Bellofatto, Kevin, Merlin, Simone, Menegon, Silvia, Perra, Andrea, Petrelli, Annalisa, Sulas, Pia, Giordano, Silvia, Columbano, Amedeo, Follenzi, Antonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362518/ https://www.ncbi.nlm.nih.gov/pubmed/28157710 http://dx.doi.org/10.18632/oncotarget.14984 |
Ejemplares similares
-
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis
por: Kowalik, Marta Anna, et al.
Publicado: (2015) -
mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma
por: Serra, Marina, et al.
Publicado: (2022) -
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis
por: Orrù, Claudia, et al.
Publicado: (2020) -
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
por: Kowalik, Marta Anna, et al.
Publicado: (2016) -
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC
por: Mattu, Sandra, et al.
Publicado: (2021)